Cargando…
Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
BACKGROUND: Malaria caused by Plasmodium vivax requires treatment of the blood‐stage infection and treatment of the hypnozoites that develop in the liver. This is a challenge to effective case management of P vivax malaria, as well as being a more general substantial impediment to malaria control. T...
Autores principales: | Milligan, Rachael, Daher, André, Graves, Patricia M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611223/ https://www.ncbi.nlm.nih.gov/pubmed/31274189 http://dx.doi.org/10.1002/14651858.CD012656.pub2 |
Ejemplares similares
-
Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022) -
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019) -
Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
por: Reddy, Pavani, et al.
Publicado: (2006) -
Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
por: Townell, Nicola, et al.
Publicado: (2012) -
Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area
por: Wångdahl, Andreas, et al.
Publicado: (2021)